Learn about the materials and technologies powering untethered micro devices in healthcare, and discover the clinical applications in oncology and vascular disease.
Built on groundbreaking research from Israel ’s Weizmann Institute of Science, Promise Bio developed the first cloud-based platform for broad epiproteomics, helping researchers uncover disease ...
“Some heart disease risk factors are genetic. …It is important to be aware of these, as well as other existing ...
For Andrew Hall, a veteran of Big Pharma-turned biotech builder, he has spent much of his recent career operating inside those constraints — and learning how to lead through them. Today, as CEO of ...
Artificial intelligence is rapidly inventing new drugs for diseases from Parkinson's disease and antibiotic-resistant superbugs to rare lung conditions.
With pressure from global competitors and recent changes in domestic policy threatening to undermine U.S. leadership in this ...
Public health has its own bracket of champions: breakthroughs that eliminated deadly diseases, revolutionized surgery, and opened entirely new doors in medicine. From vaccines to mRNA technology, ...
Biomaterials are taking medicine by storm – explore some recent preclinical advances in the field that may yield therapeutic benefits.
While current flu shots need to be updated each season, scientists are finding new ways to make vaccine that could last much longer and cover more strains.
Thermo Fisher Scientific Inc. (TMO) 47th Annual Raymond James Institutional Investor Conference March 3, 2026 9:15 AM ESTCompany ParticipantsMarc Casper ...
Oppenheimer 36th Annual Healthcare Life Sciences Conference February 26, 2026 12:00 PM ESTCompany ParticipantsBrett ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results